{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:01:58Z","timestamp":1793311318479,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.brainresbull.2021.04.006","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T06:09:37Z","timestamp":1618985377000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["The dynamics of nigrostriatal system damage and neurobehavioral changes in the rotenone rat model of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"173","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5948-9339","authenticated-orcid":false,"given":"Dmitry","family":"Troshev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniil","family":"Berezhnoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Kulikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6888-3223","authenticated-orcid":false,"given":"Denis","family":"Abaimov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Muzychuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Nalobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Stvolinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Fedorova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.brainresbull.2021.04.006_bib0005","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0166-4328(02)00180-8","article-title":"Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats","volume":"136","author":"Alam","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2021.04.006_bib0010","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neubiorev.2016.03.016","article-title":"Animal behavioral assessments in current research of Parkinson\u2019s disease","volume":"65","author":"Asakawa","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.brainresbull.2021.04.006_bib0015","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/35072550","article-title":"Experimental models of Parkinson\u2019s disease","volume":"2","author":"Beal","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.brainresbull.2021.04.006_bib0020","first-page":"514","article-title":"Neurochemical and behavioral changes in the early stage model of Parkinsonism induced by intranasal administration of MPTP to Wistar Rats","volume":"68","author":"Berezhnoy","year":"2018","journal-title":"J. High. Nerv. Activity"},{"key":"10.1016\/j.brainresbull.2021.04.006_bib0025","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"issue":"4","key":"10.1016\/j.brainresbull.2021.04.006_bib0030","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/bies.10067","article-title":"Animal models of Parkinson\u2019s disease","volume":"24","author":"Betarbet","year":"2002","journal-title":"BioEssays"},{"key":"10.1016\/j.brainresbull.2021.04.006_bib0035","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.expneurol.2009.05.017","article-title":"Stepping test in mice: a reliable approach in determining forelimb akinesia in MPTP-induced Parkinsonism","volume":"219","author":"Blume","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainresbull.2021.04.006_bib0040","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson\u2019s disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.brainresbull.2021.04.006_bib0045","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/mds.22720","article-title":"Examining Braak\u2019s hypothesis by imaging Parkinson\u2019s disease","volume":"25","author":"Brooks","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.brainresbull.2021.04.006_bib0050","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1212\/WNL.43.6.1150","article-title":"Environmental antecedents of young-onset Parkinson\u2019s disease","volume":"43","author":"Butterfield","year":"1993","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.brainresbull.2021.04.006_bib0055","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3390\/ijms18030551","article-title":"Parkinson\u2019s Disease: From Pathogenesis to Pharmacogenomics","volume":"18","author":"Cacabelos","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.brainresbull.2021.04.006_bib0060","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","article-title":"A highly reproducible rotenone model of Parkinson\u2019s disease","volume":"34","author":"Cannon","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainresbull.2021.04.006_bib0065","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1750-1326-8-14","article-title":"Behavioral characterization of the 6-hydroxidopamine model of Parkinson\u2019s disease and pharmacological rescuing of non-motor deficits","volume":"8","author":"Carvalho","year":"2013","journal-title":"Mol. Neurodegener."},{"issue":"2","key":"10.1016\/j.brainresbull.2021.04.006_bib0070","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.jcbfm.9600034","article-title":"Atorvastatin induction of VEGF and BDNF promotes brain plasticity after stroke in mice","volume":"25","author":"Chen","year":"2005","journal-title":"J. Cerebral Blood Metab."},{"issue":"2","key":"10.1016\/j.brainresbull.2021.04.006_bib0075","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0306-4522(92)90099-N","article-title":"Mesostriatal and mesolimbic dopamine uptake binding sites are reduced in Parkinson\u2019s disease and progressive supranuclear palsy: A quantitative autoradiographic study using [3H]mazindol","volume":"49","author":"Chinaglia","year":"1992","journal-title":"Neuroscience"},{"issue":"11","key":"10.1016\/j.brainresbull.2021.04.006_bib0080","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/nrn1788","article-title":"Axon degeneration mechanisms: commonality amid diversity","volume":"6","author":"Coleman","year":"2005","journal-title":"Nature Reviews Neuroscience"},{"issue":"10","key":"10.1016\/j.brainresbull.2021.04.006_bib0085","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.freeradbiomed.2008.03.005","article-title":"Oxidative and nitrative protein modifications in Parkinson\u2019s disease","volume":"44","author":"Danielson","year":"2008","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"10.1016\/j.brainresbull.2021.04.006_bib0090","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u2019s Disease: Mechanisms and Models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.brainresbull.2021.04.006_bib0095","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.nbd.2011.07.011","article-title":"Neonatal exposure to lipopolysaccharide enhances vulnerability of nigrostriatal dopaminergic neurons to rotenone neurotoxicity in later life","volume":"44","author":"Fan","year":"2011","journal-title":"Neurobiol Dis."},{"issue":"1-2","key":"10.1016\/j.brainresbull.2021.04.006_bib0100","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jns.2012.05.030","article-title":"Mitochondria, oxidative stress and neurodegeneration","volume":"322","author":"Federico","year":"2012","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.brainresbull.2021.04.006_bib0105","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.neuro.30.051606.094341","article-title":"Ventral tegmental area neurons in learned appetitive behavior and positive reinforcement","volume":"30","author":"Fields","year":"2007","journal-title":"Annu Rev Neurosci"},{"issue":"2","key":"10.1016\/j.brainresbull.2021.04.006_bib0110","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.expneurol.2004.01.023","article-title":"Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone","volume":"187","author":"Fleming","year":"2004","journal-title":"Exp Neurol"},{"key":"10.1016\/j.brainresbull.2021.04.006_bib0115","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.cellsig.2007.04.009","article-title":"Oxyl radicals, redox-sensitive signalling cascades and antioxidants","volume":"19","author":"Genestra","year":"2007","journal-title":"Cell. Signal"},{"key":"10.1016\/j.brainresbull.2021.04.006_bib0120","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.290.5493.985","article-title":"Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions","volume":"290","author":"Giasson","year":"2000","journal-title":"Science."},{"issue":"3","key":"10.1016\/j.brainresbull.2021.04.006_bib0125","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1471-4159.2003.01533.x","article-title":"Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats","volume":"84","author":"H\u00f6glinger","year":"2003","journal-title":"Journal of Neurochemistry"},{"issue":"3","key":"10.1016\/j.brainresbull.2021.04.006_bib0130","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico- pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.brainresbull.2021.04.006_bib0135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bbr.2015.04.018","article-title":"Basal ganglia circuit loops, dopamine and motivation: a review and enquiry","volume":"290","author":"Ikemoto","year":"2015","journal-title":"Behav. Brain. Res."},{"key":"10.1016\/j.brainresbull.2021.04.006_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2015.00503","article-title":"Evaluation of models of Parkinson\u2019s disease","volume":"9","author":"Jagmag","year":"2016","journal-title":"Front Neurosci"},{"key":"10.1016\/j.brainresbull.2021.04.006_bib0145","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/emm.2006.40","article-title":"Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson\u2019s disease","volume":"38","author":"Kim","year":"2006","journal-title":"Exp. Mol. Med."},{"issue":"4","key":"10.1016\/j.brainresbull.2021.04.006_bib0150","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3103\/S0096392516040064","article-title":"Carnosine prevents the development of oxidative stress under the conditions of toxic action of cadmium","volume":"71","author":"Kulikova","year":"2016","journal-title":"Moscow Univ. Biol. Sci. Bull."},{"key":"10.1016\/j.brainresbull.2021.04.006_bib0155","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/mds.22786","article-title":"The nonmotor symptoms of Parkinson\u2019s disease\u2014an overview","volume":"25","author":"Lim","year":"2010","journal-title":"Mov Disord."},{"issue":"4","key":"10.1016\/j.brainresbull.2021.04.006_bib0160","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1017\/S0317167100032212","article-title":"3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin","volume":"18","author":"Ludolph","year":"1991","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.brainresbull.2021.04.006_bib0165","first-page":"517","article-title":"\u03b1-Synuclein and tyrosine hydroxylase expression in acute rotenone toxicity","volume":"19","author":"Luo","year":"2007","journal-title":"Int. J. Mol. Med."},{"issue":"10","key":"10.1016\/j.brainresbull.2021.04.006_bib0170","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1096\/fj.08-125443","article-title":"Glutathione - a review on its role and significance in Parkinson\u2019s disease","volume":"23","author":"Martin","year":"2009","journal-title":"Faseb J."},{"issue":"1","key":"10.1016\/j.brainresbull.2021.04.006_bib0175","doi-asserted-by":"crossref","DOI":"10.1186\/s12868-018-0429-9","article-title":"Zinc and linoleic acid pre-treatment attenuates biochemical and histological changes in the midbrain of rats with rotenone-induced Parkinsonism","volume":"19","author":"Mbiydzenyuy","year":"2018","journal-title":"BMC Neuroscience"},{"key":"10.1016\/j.brainresbull.2021.04.006_bib0180","series-title":"The Structure and Function of the Dopamine Transporter and Its Role in CNS Diseases. Vitamins & Hormones","first-page":"339","author":"McHugh","year":"2015"},{"issue":"24","key":"10.1016\/j.brainresbull.2021.04.006_bib0185","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1212\/WNL.0b013e318278fe32","article-title":"Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease","volume":"79","author":"Milber","year":"2012","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.brainresbull.2021.04.006_bib0190","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s40265-014-0343-0","article-title":"Catechol-O-Methyltransferase Inhibitors in Parkinson\u2019s Disease","volume":"75","author":"M\u00fcller","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.brainresbull.2021.04.006_bib0195","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.brainres.2008.01.074","article-title":"Behavioral alterations in rotenone model of Parkinson\u2019s disease: Attenuation by co-treatment of centrophenoxine","volume":"1201","author":"Nehru","year":"2008","journal-title":"Brain Research"},{"key":"10.1016\/j.brainresbull.2021.04.006_bib0200","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.neuro.22.1.123","article-title":"Etiology and pathogenesis of Parkinson\u2019s disease","volume":"22","author":"Olanow","year":"1999","journal-title":"Annu Rev Neurosci."},{"key":"10.1016\/j.brainresbull.2021.04.006_bib0205","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.brainresbull.2021.04.006_bib0210","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the \u03b1-synuclein gene identified in families with Parkinson\u2019s disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.brainresbull.2021.04.006_bib0215","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/ana.20160","article-title":"Idiopathic hyposmia as a preclinical sign of Parkinson\u2019s disease","volume":"56","author":"Ponsen","year":"2004","journal-title":"Ann Neurol."},{"key":"10.1016\/j.brainresbull.2021.04.006_bib0220","series-title":"Limitations of Animal Models of Parkinson\u2019s Disease. Parkinson\u2019s Disease","first-page":"1","author":"Potashkin","year":"2011"},{"key":"10.1016\/j.brainresbull.2021.04.006_bib0225","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/gps.4414","article-title":"Estimating the prevalence of Parkinson\u2019s disease (PD) and proportions of patients with associated dementia and depression among the older adults based on secondary claims data","volume":"31","author":"Riedel","year":"2016","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.brainresbull.2021.04.006_bib0230","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.pnpbp.2010.06.004","article-title":"Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson\u2019s disease are predominantly associated with serotonin and dopamine","volume":"34","author":"Santiago","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.brainresbull.2021.04.006_bib0235","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.brainres.2005.04.051","article-title":"Acute intranigral infusion of rotenone in rats causes progressive biochemical lesions in the striatum similar to Parkinson\u2019s disease","volume":"1049","author":"Saravanan","year":"2005","journal-title":"Brain Research"},{"key":"10.1016\/j.brainresbull.2021.04.006_bib0240","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0891-5849(01)00480-4","article-title":"Redox environment of the cell as viewed through the redox state of the glutathione disulfide\/glutathione couple","volume":"30","author":"Schafer","year":"2001","journal-title":"Free Rad. Biol. Med."},{"issue":"11","key":"10.1016\/j.brainresbull.2021.04.006_bib0245","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s007020100004","article-title":"Neurochemical findings in the MPTP model of Parkinson\u2019s disease","volume":"108","author":"Schmidt","year":"2001","journal-title":"Journal of Neural Transmission"},{"issue":"2","key":"10.1016\/j.brainresbull.2021.04.006_bib0250","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.pathophys.2016.03.002","article-title":"Beneficial effect of antidepressants against rotenone induced Parkinsonism like symptoms in rats","volume":"23","author":"Sharma","year":"2016","journal-title":"Pathophysiology"},{"key":"10.1016\/j.brainresbull.2021.04.006_bib0255","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neuint.2018.02.010","article-title":"Neuroprotective potential of spermidine against rotenone induced Parkinson\u2019s disease in rats","volume":"116","author":"Sharma","year":"2018","journal-title":"Neurochemistry International"},{"issue":"1","key":"10.1016\/j.brainresbull.2021.04.006_bib0260","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/exnr.2002.8072","article-title":"Subcutaneous Rotenone Exposure Causes Highly Selective Dopaminergic Degeneration and \u03b1-Synuclein Aggregation","volume":"179","author":"Sherer","year":"2003","journal-title":"Experimental Neurology"},{"issue":"5","key":"10.1016\/j.brainresbull.2021.04.006_bib0265","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/mds.24954","article-title":"Premotor Parkinson\u2019s disease: concepts and definitions","volume":"27","author":"Siderowf","year":"2012","journal-title":"Mov Disord."},{"issue":"2","key":"10.1016\/j.brainresbull.2021.04.006_bib0270","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00004647-200202000-00011","article-title":"Increase in Dopamine Turnover Occurs Early in Parkinson\u2019s Disease: Evidence from a New Modeling Approach to PET18F-Fluorodopa Data","volume":"22","author":"Sossi","year":"2002","journal-title":"J. Cerebral Blood Metab."},{"key":"10.1016\/j.brainresbull.2021.04.006_bib0275","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1046\/j.1471-4159.2000.0752611.x","article-title":"In vivo labelingofmitochondrialcomplexI(NADH:ubiquinoneoxidoreductase) inratbrainusing[(3)H]dihydrorotenone","volume":"75","author":"Talpade","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainresbull.2021.04.006_bib0280","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.neuroscience.2012.11.006","article-title":"Anti-inflammatory properties rather than anti-oxidant capability is the major mechanism of neuroprotection by sodium salicylate in a chronic rotenone model of Parkinson\u2019s disease","volume":"231","author":"Thakur","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainresbull.2021.04.006_bib0285","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neuropharm.2013.11.016","article-title":"Long-term heat shock proteins (HSPs) induction by carbenoxolone improves hallmark features of Parkinson\u2019s disease in a rotenone-based model","volume":"79","author":"Thakur","year":"2014","journal-title":"Neuropharmacology"},{"issue":"18","key":"10.1016\/j.brainresbull.2021.04.006_bib0290","doi-asserted-by":"crossref","first-page":"16504","DOI":"10.1074\/jbc.M110.208447","article-title":"Alternative Mitochondrial Electron Transfer as a Novel Strategy for Neuroprotection","volume":"286","author":"Wen","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.brainresbull.2021.04.006_bib0295","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/BF00187257","article-title":"Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant","volume":"93","author":"Willner","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainresbull.2021.04.006_bib0300","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/978-1-61779-328-8_27","article-title":"Determination of Neurotransmitter Levels in Models of Parkinson\u2019s Disease by HPLC-ECD","author":"Yang","year":"2011","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.brainresbull.2021.04.006_bib0305","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1096\/fj.04-2751com","article-title":"Aggregated a-synuclein activates microglia: A process leading to disease progression in Parkinson\u2019s disease","volume":"19","author":"Zhang","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.brainresbull.2021.04.006_bib0310","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.brainres.2016.11.020","article-title":"Subcutaneous rotenone rat model of Parkinson\u2019s disease: dose exploration study","volume":"1655","author":"Zhang","year":"2017","journal-title":"Brain Res."}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923021001039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923021001039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:43:51Z","timestamp":1759783431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923021001039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":62,"alternative-id":["S0361923021001039"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2021.04.006","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The dynamics of nigrostriatal system damage and neurobehavioral changes in the rotenone rat model of Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2021.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}